Share:
COLOMBO (News 1st); Sri Lanka recorded a total of 1,914 COVID-19 cases on Friday (07), National Operations Centre for Prevention of COVID-19 Outbreak (NOCPCO).
1,889 of these cases were from the local New Year Cluster while the remaining 25 were those who tested positive for the coronavirus after returning from overseas.
Latest News
326 COVID infections from Colombo on Thursday (06)
326 COVID infections from Colombo on Thursday (06)
Written by
Share:
COLOMBO (News 1st); 326 COVID-19 cases were reported from the Colombo District on Thursday (06), said the National Operations Centre for Prevention of COVID-19 Outbreak (NOCPCO).
In addition, 309 COVID-19 cases were reported from the Kalutara District while 273 COVID-19 cases were reported from the Gampaha District.
A total of 1,895 COVID-19 infections were reported in Sri Lanka on Thursday (06).
Latest News
News in pictures dailynews.lk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailynews.lk Daily Mail and Mail on Sunday newspapers.
Posted on May 4th, 2021 Courtesy Hiru News One more review session of COVID-19 Task Force members on the control of the epidemic, chaired by General Shavendra Silva, Head, NOCPCO, Chief of Defence Staff and Commander of the Army, together with Dr Asela Gunawardena, Medical Specialist and Director General of Health Services got underway this afternoon (4) at the National Operations Centre for Prevention of COVID-19 Outbreak (NOCPCO) at Rajagiriya.
During this discussion, General Shavendra Silva updated the gathering as regards the present status of the pandemic and behaviour of the new COVID-19 variant during the 3rd wave as well as new isolated areas of the country, designed to prevent further transmission.
Canada authorizes Pfizer/BioNTech Covid-19 vaccine for children aged 12 to 15
From CNN’s Paula Newton in Ottawa
A healthcare worker fills a syringe with the Pfizer-BioNTech Covid-19 vaccine at a vaccination clinic in Vancouver, Canada, on Thursday, March 4. Canada announced Wednesday that it has approved the Pfizer-BioNTech Covid-19 vaccine for children ages 12 to 15. Jennifer Gauthier/Bloomberg/Getty Images
Canada announced Wednesday that it has authorized the Pfizer/BioNTech Covid-19 vaccine for children ages 12 to 15.
Clinical trial results of Pfizer/BioNTech s Covid-19 vaccine showed its efficacy is 100% and it is well tolerated in youths ages 12 to 15, the company said.
“The most commonly reported side effects were temporary and mild, like a sore arm, chills or fever,” said Dr. Supriya Sharma, Health Canada’s chief medical advisor.